Advertisement
Screener

LABCORP HOLDINGS INC. (LH) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

2.5 / 5 stars · 59/120 Roast Me

LABCORP HOLDINGS INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

LABCORP HOLDINGS INC. (LH) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 29.70% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2026-02-24

  • LABCORP HOLDINGS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2019-12-31 was 20.80%.
  • LABCORP HOLDINGS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2019-03-31 was 20.00%.
  • LABCORP HOLDINGS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2025 was 29.70%, a 1.00% decline from fiscal 2024.
  • LABCORP HOLDINGS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2024 was 30.00%, a 0.67% increase from fiscal 2023.
  • LABCORP HOLDINGS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2023 was 29.80%, a 4.20% increase from fiscal 2022.
  • LABCORP HOLDINGS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2022 was 28.60%, a 0.00% change from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month as first filed
2025-12-3129.70%
10-K · filed 2026-02-24
2024-12-3130.00%
10-K · filed 2026-02-24
2023-12-3129.80%
10-K · filed 2026-02-24
2022-12-3128.60%
10-K · filed 2025-02-25
2021-12-3128.60%
10-K · filed 2024-02-26
2020-12-3120.30%
10-K · filed 2023-02-28
2019-12-3120.80%
10-K · filed 2020-02-28
20.40%
10-K · filed 2022-02-25
20.80%
10-K · filed 2020-02-28
2019-03-3120.00%
10-K · filed 2020-02-28
2018-12-3118.90%
10-K · filed 2020-02-28
2017-12-3119.70%
10-K · filed 2019-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
QUEST DIAGNOSTICS INC (DGX)United States$26.096B22.09
Guardant Health, Inc. (GH)United States$23.675B-12.65
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
RadNet, Inc. (RDNT)United States$5.611B-229.65
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30